Ligand validation:5CWR

DCP: 2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE

DCP is a Ligand Of Interest in 5CWR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5CWR_DCP_B_601	90%	28%	0.104	0.986	1.7	1.2	4	3	0	0	100%	1
5CWR_DCP_A_601	84%	27%	0.118	0.98	1.72	1.24	4	5	0	0	100%	1
2PFP_DCP_A_755	71%	62%	0.136	0.957	0.65	0.8	-	1	0	0	100%	1
2PFQ_DCP_A_1438	51%	58%	0.171	0.924	0.69	0.91	-	2	0	0	100%	0.25
5CR0_DCP_B_602	46%	27%	0.211	0.948	1.72	1.23	4	5	0	0	100%	1
5DDY_DCP_C_603	44%	23%	0.208	0.935	1.86	1.32	4	5	2	0	100%	1
3IAY_DCP_A_986	99%	51%	0.058	0.986	0.9	0.98	1	2	2	0	100%	1
4YR0_DCP_A_501	98%	55%	0.067	0.986	0.83	0.91	1	2	0	0	100%	1
2HVW_DCP_C_1203	97%	53%	0.062	0.977	0.86	0.95	1	1	0	0	100%	1
4RZR_DCP_D_401	97%	47%	0.069	0.984	0.84	1.19	-	3	0	0	100%	1
7RBH_DCP_A_402	97%	57%	0.069	0.983	0.83	0.81	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.